Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05091879 · ClinicalTrials.gov registry record · NA
Preemptive Pharmacogenomics Testing Among Geriatric Patients
A NA study of Polypharmacy and Pharmacogenomic Testing, sponsored by Geisinger Clinic.
- Active
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
- 1
- Study location
NCT05091879 is a NA study of Polypharmacy and Pharmacogenomic Testing that is active but no longer recruiting, run by Geisinger Clinic. The registered enrollment target is 2,000 participants, above the 1,351-participant average among 8 other Polypharmacy trials with a reported enrollment target (48% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05091879, a NA study of Polypharmacy and Pharmacogenomic Testing, is active but no longer recruiting, sponsored by Geisinger Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this study is to conduct pharmacogenomics testing (a type of DNA test) within an aging population and measure the impact of this test on medication selection, dosing, healthcare utilization, and costs of care.
Conditions Studied
Interventions
- GENETIC Multigene pharmacogenomics test
Study Locations (1)
Pennsylvania
- Geisinger - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2023-03-28 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05091879
The ClinicalTrials.gov registry entry for NCT05091879 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,351-participant average among 8 other Polypharmacy trials with a reported enrollment target (48% higher). The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Polypharmacy appearing as the primary indexed condition, and to 1 intervention - of which Multigene pharmacogenomics test is the first listed.
NCT05091879 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05091879 about?
NCT05091879 is a clinical study titled "Preemptive Pharmacogenomics Testing Among Geriatric Patients". The primary goal of this study is to conduct pharmacogenomics testing (a type of DNA test) within an aging population and measure the impact of this test on medication selection, dosing, healthcare utilization, and costs of care.
What is the current status of trial NCT05091879?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2023-03-28. Estimated completion is 2026-06.
What conditions does trial NCT05091879 study?
This clinical trial studies the following conditions: Polypharmacy, Pharmacogenomic Testing.
What interventions are being tested in trial NCT05091879?
The interventions under investigation include: Multigene pharmacogenomics test (GENETIC).
Who is sponsoring clinical trial NCT05091879?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05091879 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polypharmacy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Medication Management in World Trade Center Responders
RECRUITING · NA
-
Effectiveness of PGx Testing
ACTIVE NOT RECRUITING · NA
-
Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial
ACTIVE NOT RECRUITING · NA
-
Pharmacist Intervention to Reduce Post-Hospitalization Utilization
ACTIVE NOT RECRUITING · NA
-
A Randomized Controlled Trial to Deprescribe for Older Patients With Polypharmacy
COMPLETED · NA
-
Tailored Medication Management Intervention
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.